A common vitamin D supplement found in medicine cabinets around the world may have an unexpected and previously unrecognized effect inside the human body. Groundbreaking research published in 2025 has revealed that taking vitamin D2 can actively reduce the levels of vitamin D3, which is the specific form of the nutrient that humans naturally synthesize when their skin is exposed to direct sunlight.
This distinction matters significantly because vitamin D2 and vitamin D3 have historically been treated by consumers and healthcare providers alike as entirely interchangeable sources of the exact same vital nutrient. While both chemical forms are capable of increasing an individual’s overall vitamin D status, a rapidly growing body of scientific evidence indicates that D3 is generally far more effective at both raising and maintaining the main biomarker of vitamin D measured in routine blood tests. Current clinical guidance from agencies such as the U.S. National Institutes of Health strongly reflects this evidence, noting that D3 tends to elevate systemic vitamin D levels to a higher degree and keep them elevated within the bloodstream for significantly longer periods than D2.
Vitamin D itself is universally recognized as essential for helping the human body absorb calcium efficiently and maintain strong, healthy bones throughout a person’s lifespan. Beyond skeletal health, the nutrient also plays critical regulatory roles in muscle performance, nerve signaling, and immune system function. In the United Kingdom, public health authorities routinely advise the general population to consider taking a daily supplement of 10 micrograms of vitamin D during the darker, colder months of the year, when natural sunlight is generally too weak for the skin to manufacture an adequate supply of the vitamin independently.
Vitamin D2 and D3 Are Not Quite the Same
Commercially available vitamin D supplements generally contain one of two distinct chemical forms. Vitamin D2, which is scientifically referred to as ergocalciferol, is commonly produced commercially from fungi, mushrooms, or yeast that have been exposed to ultraviolet light. On the other hand, vitamin D3, known chemically as cholecalciferol, is the exact same molecular form that is produced naturally in human skin following exposure to ultraviolet B radiation from the sun.
Historically, the vitamin D3 utilized in dietary supplements has frequently been derived from lanolin, a wax obtained from raw sheep’s wool during the shearing process. However, modern manufacturing has made animal-free D3 widely available, utilizing alternative natural sources such as specialized lichen. This advancement represents an exceptionally important consideration for individuals following strict vegan, vegetarian, or plant-based diets who wish to avoid animal-derived ingredients while maintaining their nutrient intake.
Once any form of vitamin D enters the human body, it must undergo several complex processing steps before it becomes biologically active. The liver is primarily responsible for converting the initial compound into 25-hydroxyvitamin D, which is the specific circulating form that doctors and clinical laboratories commonly measure during routine blood tests to estimate a patient’s overall vitamin D status. When vitamin D2 is processed, it produces 25-hydroxyvitamin D2, whereas vitamin D3 is converted into 25-hydroxyvitamin D3.
It is precisely this D3-derived biochemical form that researchers discovered could experience a notable drop after individuals ingested vitamin D2 supplements.
Vitamin D2 Was Linked to a Drop in Vitamin D3
The 2025 study, which was published in the academic journal Nutrition Reviews by a collaborative team of researchers from the University of Surrey, the John Innes Centre, and Quadram Institute Bioscience, brought together comprehensive evidence from numerous randomized controlled trials to examine this metabolic interaction more closely.
In conducting their review, the researchers evaluated 20 distinct studies, ultimately finding 11 that provided data suitable for inclusion in their primary meta-analysis. When comparing individuals who did not receive vitamin D2 against those who were actively taking the supplement, the researchers observed that the participants taking D2 exhibited significantly lower concentrations of 25-hydroxyvitamin D3 in their blood. Depending on the specific statistical methods and analytical models applied to the data, the average reduction ranged roughly from 9 to 18 nanomoles per liter.
Crucially, researchers emphasize that this finding does not imply that vitamin D2 simply flushes or removes essential vitamin D from the body, nor does it mean that taking D2 supplements is inherently harmful to human health. Vitamin D2 on its own successfully raises levels of 25-hydroxyvitamin D2 and can meaningfully contribute to an individual’s total measured vitamin D status. Instead, the genuinely surprising scientific takeaway is that artificially increasing one specific form of the nutrient appears to coincide directly with a measurable reduction in the other.
Emily Brown, a PhD Research Fellow and the lead researcher of the study from the University of Surrey’s Nutrition, Exercise, Chronobiology & Sleep Discipline, explained the significance of the findings in the context of seasonal health recommendations.
"Vitamin D supplements are important, especially between October and March, when our bodies cannot make vitamin D from sunlight in the UK," Brown stated. "However, we discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."
Why Would Vitamin D2 Lower Vitamin D3?
Despite the clarity of the trial data, scientists do not yet possess a definitive, single explanation for the exact physiological mechanisms driving this interaction.
One primary hypothesis involves the complex homeostatic mechanisms that the human body employs to tightly regulate its vitamin D levels. When the overall concentrations of various vitamin D metabolites rise inside the system, the body may naturally accelerate the metabolic breakdown, clearance, and removal of these compounds in an effort to keep internal levels strictly under control and prevent toxicity. Researchers have consequently proposed that introducing higher quantities of vitamin D2 could inadvertently accelerate the bodily disposal and degradation of existing 25-hydroxyvitamin D3 reserves.
Furthermore, earlier experimental studies have occasionally suggested that this metabolic balancing relationship may actually work in both directions, with D3 supplementation on rare occasions reducing D2-derived metabolites. Exactly how important this competitive metabolic balancing effect is for long-term human health remains an unresolved question within the scientific community.
Professor Cathie Martin, a Group Leader at the John Innes Centre who contributed to the research, highlighted the broader practical implications for public health nutrition.
"This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK," Martin noted.
That overarching objective has become increasingly practical and achievable in recent years because high-quality, plant-based, and animal-free sources of vitamin D3 are now commercially available to the public, including specialized forms of D3 derived sustainably from lichen.
D3 May Affect the Immune System Differently
The new findings also align neatly with earlier academic work suggesting that vitamin D2 and D3 may not possess identical biological effects beyond their shared basic ability to elevate circulating vitamin D levels in the blood.
A notable study published in the journal Frontiers in Immunology and led by Professor Colin Smith, also from the University of Surrey, examined how supplementation with the two different forms affected gene activity and expression within human blood cells. The research team uncovered substantial, quantifiable differences between the biological responses triggered by D2 versus D3, including distinct regulatory changes involving the human immune system. Specifically, vitamin D3 appeared to actively stimulate genetic activity associated with type I interferon signaling pathways, whereas vitamin D2 demonstrated no such effect.
Type I interferons are critical signaling proteins that help alert neighboring cells when a viral or bacterial infection is actively developing, forming an essential component of the body’s early, innate defenses against pathogens.
Professor Colin Smith discussed the immunological implications of the work, noting the potential protective role of the nutrient.
"We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signaling system in the body—a key part of the immune system that provides a first line of defense against bacteria and viruses," Smith said. "Thus, a healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."
Despite these intriguing findings, researchers caution that the results should not be interpreted as definitive proof that taking vitamin D3 will actively prevent any specific infection in everyday life. Subtle changes in cellular gene activity and immune signaling proteins do not always translate directly into a measurable reduction in illnesses among human populations, meaning larger and more comprehensive clinical trials are required to establish what these molecular differences truly mean for daily health outcomes.
Newer Evidence Adds an Important Caveat
More recent research published since the initial 2025 meta-analysis has introduced an important layer of nuance to the scientific discussion surrounding these supplements.
A separate systematic review and meta-analysis published in 2026 closely examined 26 randomized clinical trials involving vitamin D2 supplementation. That review discovered that D2 supplementation significantly reduced circulating parathyroid hormone levels and produced a small, measurable increase in blood calcium levels. These findings clearly demonstrate that vitamin D2 continues to exert meaningful, positive biological effects within the human body, even if it simultaneously coincides with a reduction in circulating D3 levels.
This physiological evidence is vital because the observed reduction in D3 should not be misinterpreted as concrete proof that vitamin D2 is medically ineffective. Current public health information from agencies like the NIH continues to state clearly that both D2 and D3 can successfully increase overall blood levels of the vitamin. The primary distinction lies in the fact that accumulated clinical data consistently favors D3 for producing a significantly larger upward shift in nutrient status and maintaining that elevation within the bloodstream for a longer duration.
This conclusion is fully consistent with previous meta-analyses that have directly compared the two forms head-to-head. One extensive analysis encompassing 24 clinical studies concluded that D3 was consistently more effective than D2 at improving overall vitamin D status, while another targeted review focusing specifically on frequent dosing schedules arrived at a remarkably similar conclusion.
Scientists Still Need to Know What the Difference Means
Ultimately, the central unanswered question facing researchers is not whether vitamin D2 is capable of reducing circulating D3 levels in the human bloodstream, as the randomized trial evidence strongly suggests that it can. Instead, what remains fundamentally uncertain is whether that specific metabolic reduction produces any clinically meaningful differences in long-term health outcomes for patients.
Researchers emphasize that additional, well-designed studies are urgently needed to determine the exact pathways by which D2 and D3 are metabolized, whether their distinct effects on immune function lead to tangible health differences, and whether D3 should officially become the universally preferred form for routine supplementation when a patient has no specific clinical reason to utilize D2.
Professor Martin Warren, the Chief Scientific Officer at the Quadram Institute, underscored the broader public health context of the ongoing research.
"Vitamin D deficiency represents a significant public health concern, especially during the winter months with significant deficiency across the UK population," Warren said. "This collaborative research effort aligns well with the Quadram Institute’s mission to deliver healthier lives through food innovation to enhance the nutrient density of the food we eat. Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."
For the time being, the accumulating scientific evidence increasingly suggests that the specific label on a vitamin D supplement matters far more than previously assumed. While both D2 and D3 can contribute meaningfully to an individual’s overall vitamin D status, they are evidently not entirely interchangeable at a metabolic level. Vitamin D3 appears to hold a clear physiological advantage when the primary clinical goal is raising and sustaining healthy vitamin D levels in the body. What scientists must now establish through continued investigation is whether those distinct biochemical differences ultimately translate into important differences for long-term human health.